BitVentures (BVC) had the highest return between August 12, 2024 and September 10, 2024 by a mid-cap US stock, returning 154.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
BitVentures (BVC) | 8/12/2024 - 9/10/2024 | 154.24% |
Strive (ASST) | 8/12/2024 - 9/10/2024 | 135.06% |
Butterfly Network (BFLY) | 8/12/2024 - 9/10/2024 | 105.15% |
Applied Digital (APLD) | 8/12/2024 - 9/10/2024 | 66.41% |
Applied Opt (AAOI) | 8/12/2024 - 9/10/2024 | 60.86% |
Oruka Therapeutics (ORKA) | 8/12/2024 - 9/10/2024 | 52.13% |
GDS (GDS) | 8/12/2024 - 9/10/2024 | 50.71% |
Travere Therapeutics (TVTX) | 8/12/2024 - 9/10/2024 | 49.65% |
Peloton Interactive (PTON) | 8/12/2024 - 9/10/2024 | 47.18% |
Nio Inc Class A ADR (NIO) | 8/12/2024 - 9/10/2024 | 44.21% |
Perpetua Resources (PPTA) | 8/12/2024 - 9/10/2024 | 41.57% |
Telesat (TSAT) | 8/12/2024 - 9/10/2024 | 40.01% |
Amylyx Pharmaceuticals (AMLX) | 8/12/2024 - 9/10/2024 | 40% |
Compass (COMP) | 8/12/2024 - 9/10/2024 | 39.25% |
Skeena Resources (SKE) | 8/12/2024 - 9/10/2024 | 37.29% |
Clover Health Investments (CLOV) | 8/12/2024 - 9/10/2024 | 36.56% |
Intapp (INTA) | 8/12/2024 - 9/10/2024 | 35.8% |
Gitlab (GTLB) | 8/12/2024 - 9/10/2024 | 34.26% |
Relay Therapeutics (RLAY) | 8/12/2024 - 9/10/2024 | 33.73% |
Pharvaris (PHVS) | 8/12/2024 - 9/10/2024 | 33.08% |
CAVA (CAVA) | 8/12/2024 - 9/10/2024 | 33.03% |
Erasca (ERAS) | 8/12/2024 - 9/10/2024 | 28.63% |
Xpeng (XPEV) | 8/12/2024 - 9/10/2024 | 28.11% |
Argan (AGX) | 8/12/2024 - 9/10/2024 | 27.97% |
AtriCure (ATRC) | 8/12/2024 - 9/10/2024 | 27.23% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.